The Evaluate the antidiabetic and hypolipidemic potential of the hydroalcoholic extract of crateva magna root (haecmr) and eugenia jambolana seed in streptozotocin (stz)-induced diabetic rats

Section: Articles Published Date: 2023-07-09 Pages: 01-20 Views: 0 Downloads: 0

Authors

  • NEERAJ GUPTA PG Scholar, College of Pharmacy, Dr. APJ Abdul Kalam University, Indore
  • DR. SOURABH JAIN Associate Professor, College of Pharmacy, Dr. APJ Abdul Kalam University, Indore
  • RAGINI BUNDELA Assistant Professor, College of Pharmacy, Dr. APJ Abdul Kalam University, Indore
  • DR. KARUNAKAR SHUKLA Professor & Principal, College of Pharmacy, Dr. APJ Abdul Kalam University, Indore M.P.
  • NEHA JAIN isiting Research Associate, Pinnacle Biomedical Research Institute, Bhopal MP India *Corresponding Author, Email ID: raginibundela34@gmail.com
Download PDF

Abstract

The present study aimed to evaluate the antidiabetic and hypolipidemic potential of the hydroalcoholic extract of Crateva magna root (HAECMR) and Eugenia jambolana seed in streptozotocin (STZ)-induced diabetic rats. Plant materials were collected from the Bhopal region of Madhya Pradesh, India, and authenticated. Extraction was performed using 70% ethanol via Soxhlet apparatus. Preliminary phytochemical screening confirmed the presence of flavonoids, alkaloids, glycosides, tannins, terpenoids, and saponins. Acute oral toxicity was assessed according to OECD-423 guidelines, establishing safety up to 300 mg/kg body weight.Thirty male Wistar rats were divided into five groups and treated for 21 days. Diabetes was induced using STZ, and animals were treated with HAECMR at two doses (100 and 300 mg/kg), Glibenclamide (10 mg/kg), or left untreated (diabetic control). Biochemical parameters including blood glucose, total cholesterol, triglycerides, HDL, LDL, and VLDL were measured at regular intervals. The Oral Glucose Tolerance Test (OGTT) was also performed to assess glucose clearance.Results indicated that HAECMR significantly reduced fasting blood glucose and improved lipid profiles in a dose-dependent manner. The 300 mg/kg dose showed effects comparable to Glibenclamide. Treated groups also exhibited improved plasma insulin levels and recovery of body weight. The observed pharmacological activities are likely attributed to the phytoconstituents identified in the extract.

Keywords

Crateva magna, Eugenia jambolana, antidiabetic activity, hypolipidemic effect, streptozotocin, phytochemical screening, OGTT